Company Overview

Development Stage

About the Company

Yueyang Pharmaceutical Development Co., Ltd. is headquartered in China Medical City, Taizhou, and has a wholly-owned subsidiary in San Diego, USA. Yueyang Pharmaceutical mainly focuses on the development of sustained-release and controlled-release platform technologies and the development of new formulations and innovative drugs, serving as an international specialized platform technology company for sustained-release and controlled-release formulations. The company has successfully developed sustained-release and controlled-release platform technologies Mech-trol®, Bi-lock®, and U-trol®, which are applied to the development of new drugs in the United States (via the 505(b)(2) pathway) and improved new drugs in China (chemical class 2.2) to meet unmet clinical needs. The company also focuses on the development of generic drugs with promising market prospects, high technical barriers, and difficulty in imitation for the US and Chinese markets, rapidly enhancing the company's market value and profitability.

The founder of the company, Dr. Wen Xiaoguang, is a national distinguished expert under the "*" program, and all core team members are overseas-returned doctoral scientists with extensive R&D and industrialization experience and advanced management concepts. The company has established a complete R&D management system and operational procedures, with all core R&D and production instruments and equipment being high-end imported products. Employees with master's or doctoral degrees account for 30% of the total workforce. * global first-in-class new drugs will enter international clinical trials within the year, and * US generic drugs are expected to receive US production approval in 2018. We welcome talented individuals to join Yueyang and create a bright future together!

"Yueyang cares for human health, and the world focuses on Yueyang technology."

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (1 rounds)

Manage
C轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 1.5亿人民币
  • Investor: 上海医药,华美国际集团,乾...

How Fast Is Hiring Growing? (24 open positions)

Manage
Note: How fast is hiring at Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd. growing? 2025: 13 openings (down 50%), 2024: 26 openings (up 37%), 2023: 19 openings (up 58%), 2022: 12 openings (down 83%), 2021: 70 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd. growing? Master's recruitment over the years: 2026: 16 openings (up 285%), 2024: 2 openings (up 37%), 2023: 1 openings (up 58%), 2022: 1 openings (down 83%), 2021: 2 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd.? Based on an analysis of 's job postings over the past year, "生物/制药/化工/环保类" demand: 22%, "医疗卫生/美容保健类": 12%, "其他(研发和技术类)": 10%, "科研类": 8%, "机械/仪器仪表类": 6%, "计算机/网络/技术类": 6%. For reference only.

— What Are the Salaries Like? (50 records)

Manage
salary range: 2K - 50K, 62% of roles pay ¥6-15K
Note: salary statistics are based on 50 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd.?62% of positions earn 6-15K, Fresh graduate salary: ¥2.0K。销售类 average salary ¥17.1K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd.? We provide: bd,分析,qc,研究员,实习生,项目经理,qa,临床,生产技术,药物警戒,运维,ma,ra,制剂研究,医学总监,工艺员,检验,法务,生产总监,生产经理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    30.8% of total 30.8%
  • 经营管理类
    28.8% of total 28.8%
  • 工厂生产类
    25% of total 25%
  • 生物/制药/化工/环保类
    21.2% of total 21.2%

Education

  • 本科
    48.1% of total 48.1%
  • 硕士
    30.8% of total 30.8%
  • 大专
    13.5% of total 13.5%
  • 不限
    5.8% of total 5.8%

Experience

  • 5-10年
    42.3% of total 42.3%
  • 3-5年
    40.4% of total 40.4%
  • 不限
    7.7% of total 7.7%
  • 应届生
    5.8% of total 5.8%
View Detailed Analysis

What does Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd. require? Who is Yueyang Pharmaceutical Development (Guangzhou) Co., Ltd. hiring? recruitment: 销售类占比最多占30.8%,其次是经营管理类占28.8%. What education can get in at ? 本科占比最多占48.1%,其次是硕士占30.8%. High education required at ? 硕士占30.8%. Work experience required at ? 5-10年占比最多占42.3%,其次是3-5年占40.4%. Where are the job locations at ? 泰州占比最多占50%,其次是广州占50%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 2,017.9898万(元)
Legal Representative: XIAOGUANG WEN
Date Established:
Credit Code: 91321291590021126W
Registered Address: 广州市黄埔区开源大道11号C1栋201室

Partners & Suppliers

合作进行药物制剂技术研发 Source
供应商 高校/研究院
产学研合作,共同开发新型缓控释制剂 Source
供应商 高校/研究院
共建缓控释制剂联合实验室 Source
供应商 高校/研究院
联合开展缓控释制剂技术研究及人才培养 Source
供应商 高校/研究院
合作开发缓控释制剂品种 Source
合作客户 制药企业

People who follow this company also follow

Competitors (Similar Companies)

“Dedicated to the research, development, production, and commercializat”
制药/药业 医药 生产 医药分析
“Leading manufacturer of Tibetan medicine in China”
“Continuously innovating to bring patients medicines that significantly”
生物制品 疫苗 疫苗生产 人用疫苗
制药/药业 生物制品 抗生素 中成药
制药/药业 医药 维生素 葡萄糖
“Products for the diagnosis and treatment of allergic diseases”
卫生材料 药物研发 生物制药 新药研发
生物科技/生物工程 麦芽糖 淀粉糖 山梨糖醇
医药 制药/药业 原料药 健康科技
医药 创新药 药物研发 产业园区开发
制药/药业 医药 生物制药 神经系统疾病药物
生产基地
“Rapid test product R&D and manufacturer”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates